Cargando…
Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses
The live attenuated yellow fever virus (YFV) vaccine 17D stands as a “gold standard” for a successful vaccine. 17D was developed empirically by passaging the wild-type Asibi strain in mouse and chicken embryo tissues. Despite its immense success, the molecular determinants for virulence attenuation...
Autores principales: | Fernandez-Garcia, Maria Dolores, Meertens, Laurent, Chazal, Maxime, Hafirassou, Mohamed Lamine, Dejarnac, Ophélie, Zamborlini, Alessia, Despres, Philippe, Sauvonnet, Nathalie, Arenzana-Seisdedos, Fernando, Jouvenet, Nolwenn, Amara, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Microbiology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752603/ https://www.ncbi.nlm.nih.gov/pubmed/26861019 http://dx.doi.org/10.1128/mBio.01956-15 |
Ejemplares similares
-
Genomic diversity contributes to the neuroinvasiveness of the Yellow fever French neurotropic vaccine
por: Bakoa, Florian, et al.
Publicado: (2021) -
Flavivirus Entry Receptors: An Update
por: Perera-Lecoin, Manuel, et al.
Publicado: (2013) -
A virus‐derived microRNA targets immune response genes during SARS‐CoV‐2 infection
por: Singh, Meetali, et al.
Publicado: (2021) -
Zika Virus Requires the Expression of Claudin-7 for Optimal Replication in Human Endothelial Cells
por: Zoladek, Jim, et al.
Publicado: (2021) -
Midgut barriers prevent the replication and dissemination of the yellow fever vaccine in Aedes aegypti
por: Danet, Lucie, et al.
Publicado: (2019)